Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Psyched Wellness (PSYC) will be participating in the upcoming H.C. Wainwright’s Psychiatry and Beyond Virtual Conference on June 17
  • Conference information, registration and a link to the webcast are available on H.C. Wainwright’s Events website
  • Psyched Wellness Ltd. is a Canadian-based health supplements company
  • Psyched Wellness Inc. (PSYC) opened trading at C$0.30 per share

Psyched Wellness (PSYC) will be participating in the upcoming H.C. Wainwright’s Psychiatry and Beyond Virtual Conference on Thursday, June 17 2021.

For more information regarding these investor conferences, please visit the sponsor’s conference website above.

To schedule a one-on-one meeting with management please reach out to your conference representative or the company’s investor contact.

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.

Psyched Wellness is developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: the promotion of stress relief, relaxation and assist with restful sleeping.

Psyched Wellness Inc. (PSYC) opened trading at C$0.30 per share.

More From The Market Herald

" Optimi Health (CSE:OPTI) acquires catalog of psychedelic and functional mushroom genetics

Optimi Health (OPTI) has acquired a catalog of psilocybin and functional mushroom strains.

" Nirvana Life Sciences Inc (CSE:NIRV) signs LOI with Innovate Phytotechnologies Inc

Nirvana Life Sciences (NIRV) has  signed a letter of intent with Innovate Phytotechnologies Inc. (INVP)
Clearmind Medicine - CEO, Adi Zuloff Shani.

" Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA

Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022.
Red Light Holland - Advisor, Akwasi Owusu Bempah.

" Red Light Holland (CSE:TRIP) adds Akwasi Owusu-Bempah to Advisory Board

Red Light Holland (TRIP) has hired drug law expert Akwasi Owusu-Bempah as its newest advisor.